<p>Cloudbreak (02592.HK) announced its 2025 annual results, with losses narrowing to USD 67.66 million, compared to a loss of USD 99.13 million in the same period last year; loss per share is USD 0.1. No dividend is declared</p>

159506

520880

513700

<p>Cloudbreak announced its 2025 annual results, with losses narrowing to USD 67.66 million, compared to a loss of USD 99.13 million in the same period last year; the loss per share is USD 0.1. No dividend is declared</p>

AASTOCKS

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Penghua CSI HK Connect Health Care Composite ETF

First Trust NYSE Arca Biotech Index Fd

E Fund CSI 300 Health Care ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Yinhua CSI Innovative Drugs Industry ETF

Minsheng Royal CSI Biotechnology Theme ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Guotai CSI Bio-medicine ETF

ChinaAMC CSI Biotechnology Theme ETF

Bosera Hang Seng Health Care ETF(QDII)

ChinaAMC SSE Health Care ETF Initiating Fund

CLOUDBREAK-B

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

E Fund CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

"Performance" Cloudbreak's annual loss narrowed to USD 67.66 million